Last reviewed · How we verify

L-CARNOSINE

Cairo University · FDA-approved active Small molecule Quality 6/100

L-CARNOSINE is a Small molecule drug developed by Cairo University. It is currently FDA-approved. Also known as: CARNOSINE, Carnosine, L Carnosine.

At a glance

Generic nameL-CARNOSINE
Also known asCARNOSINE, Carnosine, L Carnosine
SponsorCairo University
ModalitySmall molecule
Therapeutic areaMetabolic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about L-CARNOSINE

What is L-CARNOSINE?

L-CARNOSINE is a Small molecule drug developed by Cairo University.

Who makes L-CARNOSINE?

L-CARNOSINE is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).

Is L-CARNOSINE also known as anything else?

L-CARNOSINE is also known as CARNOSINE, Carnosine, L Carnosine.

What development phase is L-CARNOSINE in?

L-CARNOSINE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing